0.68 - 0.75
0.33 - 0.86
12.96M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-29.45%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-61.53%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-496.72%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-496.72%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-64.24%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-27.12%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-27.12%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
29.22%
Slight or no buybacks while 0360.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
29.28%
Diluted share count expanding well above 0360.HK's 0.00%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Dividend reduction while 0360.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-9.10%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-2.79%
Negative FCF growth while 0360.HK is at 125.14%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-48.70%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-49.30%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-53.69%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-963.10%
Negative 10Y OCF/share CAGR while 0360.HK stands at 545.55%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-956.34%
Negative 5Y OCF/share CAGR while 0360.HK is at 147.38%. Joel Greenblatt would question the firm’s operational model or cost structure.
-34.05%
Negative 3Y OCF/share CAGR while 0360.HK stands at 279.64%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-208.22%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-514.36%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-282.74%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
135.21%
10Y equity/share CAGR 1.25-1.5x 0360.HK's 110.35%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
-6.80%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-26.90%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-100.00%
Cut dividends over 10 years while 0360.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while 0360.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 0360.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-5.13%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
22.07%
We show growth while 0360.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
9.37%
Positive asset growth while 0360.HK is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-26.90%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
73.53%
We have some new debt while 0360.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-37.45%
Our R&D shrinks while 0360.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-33.04%
We cut SG&A while 0360.HK invests at 200.10%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.